052260 — Hyundai BioLand Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Market Cap
KR₩152bn
Enterprise Value
KR₩162bn
Revenue
KR₩120bn

Annual balance sheet for Hyundai BioLand Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,381	14,742	23,074	23,076	26,000
Net Total Accounts Receivable
Net Total Receivables	12,480	14,227	12,144	13,204	13,315
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57,163	63,974	71,216	79,781	107,139
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	108,997	83,887	80,153	78,547	67,025
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	187,658	172,744	176,097	184,069	194,726
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35,507	46,721	46,144	46,984	55,754
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	50,429	47,394	46,811	48,085	56,718
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	137,229	125,350	129,287	135,984	138,008
Total Liabilities & Shareholders' Equity	187,658	172,744	176,097	184,069	194,726
Total Common Shares Outstanding